Logo

AVAH

Aveanna Healthcare Holdings Inc.

AVAH

Aveanna Healthcare Holdings Inc. • NASDAQ
$9.34 ▲ 0.76% (+0.07)
Market Cap $1.95 B
52w High $10.32
52w Low $3.67
Dividend Yield 0%
P/E 25.24
Volume 379.26K
Outstanding Shares 208.91M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $621.942M ▲ $143.953M ▲ $14.064M ▼ 2.261% ▼ $0.07 ▼ $55.67M ▼
Q2-2025 $589.553M ▲ $130.766M ▼ $27.025M ▲ 4.584% ▲ $0.13 ▲ $87.11M ▲
Q1-2025 $559.224M ▲ $131.757M ▲ $5.193M ▼ 0.929% ▼ $0.027 ▼ $51.783M ▼
Q4-2024 $519.872M ▲ $125.951M ▲ $29.18M ▲ 5.613% ▲ $0.15 ▲ $70.572M ▲
Q3-2024 $509.023M $125.675M $-42.843M -8.417% $-0.22 $19.261M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $145.866M ▲ $1.81B ▲ $1.801B ▲ $9.914M ▲
Q2-2025 $100.738M ▲ $1.771B ▲ $1.782B ▲ $-11.262M ▲
Q1-2025 $71.494M ▼ $1.661B ▼ $1.759B ▼ $-98.669M ▲
Q4-2024 $84.288M ▲ $1.663B ▲ $1.785B ▼ $-122.09M ▲
Q3-2024 $78.462M $1.644B $1.799B $-154.981M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q2-2025 $27.025M ▲ $51.569M ▲ $-15.982M ▼ $-6.343M ▼ $29.244M ▲ $50.44M ▲
Q1-2025 $5.193M ▼ $-8.632M ▼ $-2.348M ▼ $-1.814M ▲ $-12.794M ▼ $-10.98M ▼
Q4-2024 $29.18M ▲ $13.406M ▼ $-1.529M ▲ $-6.051M ▼ $5.826M ▼ $11.877M ▼
Q3-2024 $-42.843M ▼ $29.394M ▲ $-2.213M ▼ $3.62M ▼ $30.801M ▲ $27.181M ▲
Q2-2024 $13.906M $1.809M $-1.269M $4.514M $5.054M $540K

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Home Health And Hospice
Home Health And Hospice
 $110.00M ▲$60.00M ▼$60.00M ▲$60.00M ▲
Medical Solutions
Medical Solutions
 $90.00M ▲$40.00M ▼$40.00M ▲$50.00M ▲
Private Duty Services
Private Duty Services
 $830.00M ▲$460.00M ▼$490.00M ▲$510.00M ▲

Five-Year Company Overview

Income Statement

Income Statement Revenue has grown steadily over the past several years, and the core service business appears to be scaling. Profitability has improved meaningfully from the deep losses seen a few years ago, with operating performance now hovering around breakeven to modestly positive. However, the company is still losing money at the bottom line, even if those losses are much smaller than before. This picture suggests a business that is moving in the right direction operationally, but has not yet proven it can consistently turn healthy revenue into durable net profits. Any setback in reimbursement rates, wage pressure, or integration costs could quickly strain margins again.

Balance Sheet

Balance Sheet The balance sheet shows a business carrying a heavy debt load relative to its size, with only a small cash cushion. Equity has turned negative in recent years, reflecting cumulative losses and prior write-downs. This combination points to a highly leveraged capital structure and limited room for error. While total assets are fairly stable, the reliance on borrowed money heightens sensitivity to interest costs, lender terms, and operating volatility. The company’s financial flexibility is therefore more constrained than that of a lightly levered peer.

Cash Flow

Cash Flow Cash generation has improved from earlier years when operations consumed cash. Recently, the company has been able to produce a small but positive stream of cash from its day‑to‑day activities, and its spending on equipment and technology is modest, leading to slightly positive free cash flow. That said, the cash cushion remains thin and the margin for absorbing shocks is narrow. The business looks just past the “cash burn” phase, but not yet in a position of strong self‑funded growth, especially given ongoing interest and debt service needs.

Competitive Edge

Competitive Edge Aveanna operates in home‑based care with a focus on medically complex and often pediatric patients, which is a specialized niche with fewer direct competitors and high ongoing demand. Its national footprint, diversified service lines (private duty nursing, home health, hospice, and medical solutions), and established payer relationships give it notable scale advantages versus many smaller, local providers. However, the industry remains fragmented and exposed to reimbursement changes and labor shortages, especially for skilled nurses. Aveanna’s strengths lie in its scale, specialization, and payer partnerships, but it operates in a structurally challenging environment where staffing and regulatory risk are constant concerns.

Innovation and R&D

Innovation and R&D The company is clearly leaning on technology to sharpen its edge. Telehealth offerings, in‑home tablets with proprietary software, integrated electronic records, and partnerships for advanced data analytics are all aimed at improving care coordination, reducing hospitalizations, and making operations more efficient. Aveanna is also investing in modern infrastructure and system consolidation, which can support value‑based care models and future digital tools. In addition, it uses targeted acquisitions to expand services and geography rather than traditional lab‑style R&D. The upside is a more data‑driven, scalable care platform; the risk is execution – integrating systems, cultures, and acquired businesses while maintaining clinical quality and cost control.

Summary

Overall, Aveanna looks like a specialized home‑care provider that has grown revenue steadily and is making visible progress in repairing its profitability and cash flow. Its focus on medically complex patients, national scale, and technology‑enabled care platform provide a defensible position in a difficult, labor‑intensive segment of healthcare. At the same time, the company carries substantial debt, runs with a thin cash buffer, and still posts net losses, which increases its vulnerability to operational setbacks or policy changes. Future performance will likely hinge on its ability to sustain margin improvement, manage leverage, execute on digital and integration initiatives, and navigate ongoing reimbursement and staffing pressures in the home‑care market.

NEWS

November 6, 2025 · 6:30 AM UTC

Aveanna Healthcare Holdings Announces Third Quarter Financial Results and Revised 2025 Outlook

Read more

October 21, 2025 · 9:50 PM UTC

Aveanna Announces Pricing of Secondary Offering of Common Stock

Read more

October 21, 2025 · 4:20 PM UTC

Aveanna Announces Launch of Secondary Offering of Common Stock

Read more

October 21, 2025 · 4:15 PM UTC

Aveanna Healthcare Holdings Announces Preliminary Third Quarter Financial Results

Read more

September 26, 2025 · 7:30 AM UTC

Aveanna to Participate at the Deutsche Bank Annual Leveraged Finance Conference

Read more